- Professionals working with vector-based medicines who want to enhance their understanding of the technologies behind these drug products.
- Individuals looking to learn from industry leaders and in-house experts on vector characterization.
- Those interested in gaining a deeper understanding of the development process and challenges associated with vector-based therapies.
- Anyone seeking insights into analytical method development techniques.
- Individuals eager to connect with experts and explore the latest advancements in nanoparticle vector characterization.
- Characterization of nanoparticles used in viral and non-viral vectors for mRNA vaccines, drug delivery systems, and clinical gene therapies.
- Understanding key physical attributes of vector-based drug products and their impact on critical quality attributes (CQAs), including safety and efficacy.
- Case studies on viral vectors and lipid-based nanoparticles for mRNA vaccines, among others.
- Overview of Malvern Panalytical solutions for vector-based drug development.
arrow
Unlocking Vector-Based Therapies: Advanced Characterization Strategies
June 10, 2025 | 9:30 AM - 2 PM | In-Person
Seattle Children's Research Institute: B. Wayne Hughes Building | 1920 Terry Ave, Seattle WA 98101 | Cure Event Space 01-750 Meeting Room
About The Event
This free in-person workshop focuses on the essential technologies utilized in the research and development of viral and non-viral vectors for vector-based therapies. Key topics will include the characterization of vector-based products, addressing critical quality attributes, understanding empty-full content, and insights into the structural characterization of non-viral vectors. This session will be particularly relevant for professionals involved in vector-based medicines who wish to deepen their understanding of the technologies that underpin these drug products.
More Information
Who should attend?
What will you learn?
Don’t miss out - book your place
facebook twitterrssinstagramlinkedinyoutube